当前位置:首页 - 行情中心 - 国新健康(000503) - 财务分析 - 利润表

国新健康

(000503)

  

流通市值:88.98亿  总市值:97.43亿
流通股本:8.99亿   总股本:9.84亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入160,912,265.05100,123,029.0655,766,199.77311,079,455.6
营业收入160,912,265.05100,123,029.0655,766,199.77311,079,455.6
二、营业总成本281,887,491.24191,896,00699,793,458.91422,919,180.82
营业成本157,322,160108,178,136.0657,572,997.62246,620,367.27
税金及附加1,030,003.32598,610.77266,047.811,960,741.67
销售费用34,715,667.3220,286,706.48,515,293.5632,940,929.89
管理费用84,724,514.4560,190,964.3631,696,816.76130,794,187.59
研发费用967,945.83967,945.83967,945.839,649,308.29
财务费用3,127,200.321,673,642.58774,357.33953,646.11
其中:利息费用3,385,152.031,827,957.26691,766.591,984,809.77
其中:利息收入427,836.82320,951.52163,953.281,584,539.01
加:公允价值变动收益---14,419,070.45
加:投资收益3,734,031.812,697,930.25335,268.914,019,750.93
资产处置收益47,020.7715,246.8-7,806.19
资产减值损失(新)735,085.43268,860.312,096,515.06-1,761,362.08
信用减值损失(新)-444,250.36-1,030,064.58-1,202,734.089,670,781.84
其他收益4,276,961.27830,715.97312,113.78950,254.35
营业利润平衡项目0000
四、营业利润-112,626,377.27-88,990,288.19-42,486,095.47-84,533,423.54
加:营业外收入6,654,749.446,561,522.191,000,000.621,565,283.09
减:营业外支出1,722,550.311,659,950.41,637,817.95218,810.24
利润总额平衡项目0000
五、利润总额-107,694,178.14-84,088,716.4-43,123,912.8-83,186,950.69
减:所得税费用869,545.87869,433.87742,868.161,277,520.03
六、净利润-108,563,724.01-84,958,150.27-43,866,780.96-84,464,470.72
持续经营净利润-108,563,724.01-84,958,150.27-43,866,780.96-84,464,470.72
归属于母公司股东的净利润-108,545,358.89-84,952,868.7-43,865,115.01-84,471,751.01
少数股东损益-18,365.12-5,281.57-1,665.957,280.29
(一)基本每股收益-0.12-0.09-0.05-0.09
(二)稀释每股收益-0.12-0.09-0.05-0.09
八、其他综合收益589,044.52714,650.26-258,502.637,817,922.5
归属于母公司股东的其他综合收益589,044.52714,650.26-258,502.637,817,922.5
九、综合收益总额-107,974,679.49-84,243,500.01-44,125,283.59-76,646,548.22
归属于母公司股东的综合收益总额-107,956,314.37-84,238,218.44-44,123,617.64-76,653,828.51
归属于少数股东的综合收益总额-18,365.12-5,281.57-1,665.957,280.29
公告日期2023-10-282023-08-252023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑